Whether the effect of glucosinolates on cholesterol metabolism might be beneficial in the prevention of CVD needs further investigation
N Engl J Med 392(6):612615 Rosenstock J, Frias J, Jastreboff AM, Du Y, Lou J, Gurbuz S, Thomas MK, Hartman ML, Haupt A, Milicevic Z, Coskun T (2023) Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
Step 2: Draw Air Remove the cap from the syringe
PlexusDx obtains your kidney function tests (estimated glomerular filtration rate, or eGFR) prior to prescribing semaglutide or tirzepatide
You won't be waking up to pee as often at night
If you need metabolic improvement, start with MOTS-c